PAGAN, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 3.781
AS - Asia 3.691
EU - Europa 2.421
SA - Sud America 540
AF - Africa 59
OC - Oceania 16
Totale 10.508
Nazione #
US - Stati Uniti d'America 3.716
SG - Singapore 1.139
VN - Vietnam 980
DE - Germania 615
CN - Cina 597
IT - Italia 583
HK - Hong Kong 549
BR - Brasile 428
RU - Federazione Russa 415
SE - Svezia 250
IE - Irlanda 172
ID - Indonesia 94
IN - India 78
GB - Regno Unito 77
FR - Francia 75
KR - Corea 66
AR - Argentina 49
CA - Canada 43
UA - Ucraina 35
NL - Olanda 33
JP - Giappone 30
AT - Austria 29
FI - Finlandia 28
BD - Bangladesh 25
TR - Turchia 25
ZA - Sudafrica 23
EC - Ecuador 22
DK - Danimarca 21
PL - Polonia 21
MX - Messico 17
ES - Italia 16
IQ - Iraq 16
IR - Iran 16
AU - Australia 14
PK - Pakistan 14
CO - Colombia 12
PY - Paraguay 12
RO - Romania 10
MY - Malesia 8
CH - Svizzera 7
CZ - Repubblica Ceca 7
ET - Etiopia 7
EG - Egitto 6
TN - Tunisia 6
BE - Belgio 5
BG - Bulgaria 5
CL - Cile 5
DZ - Algeria 5
LB - Libano 5
PE - Perù 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
GR - Grecia 4
IL - Israele 4
KG - Kirghizistan 4
LT - Lituania 4
TW - Taiwan 4
AE - Emirati Arabi Uniti 3
MO - Macao, regione amministrativa speciale della Cina 3
PH - Filippine 3
RS - Serbia 3
TH - Thailandia 3
VE - Venezuela 3
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
GE - Georgia 2
GH - Ghana 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
KZ - Kazakistan 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
PS - Palestinian Territory 2
SN - Senegal 2
UG - Uganda 2
UY - Uruguay 2
AL - Albania 1
BB - Barbados 1
BJ - Benin 1
BW - Botswana 1
EE - Estonia 1
MA - Marocco 1
NG - Nigeria 1
NP - Nepal 1
PA - Panama 1
PT - Portogallo 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
Totale 10.508
Città #
Ann Arbor 819
Singapore 597
Hong Kong 545
Frankfurt am Main 523
Ashburn 303
Ho Chi Minh City 290
Fairfield 259
Wilmington 212
Hanoi 210
Milan 176
Dublin 163
Dallas 150
Houston 141
Hefei 125
Santa Clara 125
Chandler 116
New York 111
Seattle 107
Woodbridge 94
Beijing 89
Princeton 88
Jakarta 82
Cambridge 78
Los Angeles 68
Dearborn 54
Moscow 54
Dong Ket 49
Seoul 48
Chicago 47
Altamura 45
Lawrence 43
San Diego 40
Shanghai 40
The Dalles 39
Nanjing 32
Guangzhou 31
Buffalo 28
Biên Hòa 27
Ha Long 27
Munich 27
Da Nang 26
São Paulo 26
Haiphong 22
Nuremberg 22
Tokyo 19
Thái Nguyên 18
Warsaw 18
Jacksonville 17
Sacramento 17
Ardea 16
Quận Bình Thạnh 16
Hải Dương 15
London 15
Toronto 15
Andover 13
Kent 13
Vienna 13
Boardman 12
Mumbai 12
Naples 12
Quận Một 12
Rio de Janeiro 12
Seregno 12
Umeå 12
Carate Brianza 11
Dhaka 11
Hangzhou 11
Helsinki 11
Salt Lake City 11
Brasília 10
Chennai 10
Monza 10
Columbus 9
Lappeenranta 9
Ninh Bình 9
Porto Alegre 9
Pune 9
Quận Phú Nhuận 9
Redmond 9
Rome 9
Stockholm 9
Tampa 9
Vinh 9
Belo Horizonte 8
Bắc Giang 8
Curitiba 8
Montreal 8
Paris 8
Vũng Tàu 8
Bologna 7
Brooklyn 7
Changsha 7
Denver 7
Edirne 7
Johannesburg 7
Nanchang 7
Pavia 7
Quito 7
Quận Tân Phú 7
Turku 7
Totale 6.796
Nome #
Joinpoint regression analysis with time-on-study as time-scale. Application to three Italian population-based cohort studies 545
Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis 423
Laryngeal cancer mortality trends in European countries 329
Male breast cancer: a multicenter study to provide a guide for proper management 295
Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study 287
Invasive Pleomorphic Lobular Carcinoma of the breast: Clinicopathological features, treatment patterns and outcomes 287
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 264
Sex-based differences of the Tumor mutational burden and T-cell inflammation of the tumor microenvironment 253
Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ 244
Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study 243
Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers 234
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast 232
Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis 229
Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial 226
Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines 222
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis 208
Endocrine-responsive lobular carcinoma of the breast: Features associated with risk of late distant recurrence 191
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 190
"Heterogeneity of treatment effect on patients' long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer." 185
Sex-based differences in cancer immunotherapy efficacy 182
Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial 176
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials 174
Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.” 174
Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis 171
Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up 165
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 162
Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland 160
Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy 153
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients 146
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients 144
Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study 141
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer 140
Evaluation of endocrine therapy and patients preferences in early breast cancer: results of Elena study 138
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion 137
Association of prebiotic fiber intake with colorectal cancer risk: the PrebiotiCa study 136
Comparative Efficacy of Classic Versus Horizontal Incision Techniques in Skin-Reducing Mastectomy: A Single Center Retrospective Analysis 134
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 134
Development and Validation of a Natural Language Processing Algorithm for Extracting Clinical and Pathological Features of Breast Cancer From Pathology Reports 132
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 129
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy 127
Different Response to Immunotherapy According to Melanoma Histologic Subtype 126
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) 125
Intra- inter-observer repeatability in liver computed tomography volumetry in patients undergoing radioembolization simulation 124
Prognostic impact of baseline immunologic profile in aggressive b-cell non-hodgkin's lymphomas 123
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy 120
Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer? 120
How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance? 116
Shifting from axillary dissection to targeted axillary surgery after neoadjuvant treatment: the evolving management of occult breast cancer in a monoinstitutional series of 114 patients 115
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer 114
How to Perform Repeat Sentinel Node Biopsy Safely After a Previous Mastectomy: Technical Features and Oncologic Outcomes 113
Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis 112
Results of the Italian cross-sectional web-based survey “Nutrition and breast cancer, what would you like to know?” An attempt to collect and respond to patients’ information needs, through social media 109
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations 106
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment - Authors' reply 100
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 99
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates 99
Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center 95
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 91
Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis 90
Pegylated liposomal doxorubicin (Caelyx®) as adjuvant treatment in early-stage luminal b-like breast cancer: A feasibility phase II trial 89
Comparison of Trends in Mortality from Coronary Heart and Cerebrovascular Diseases in North and South America: 1980 to 2013 85
Systematic review and meta-analysis of post-progression outcomes in ER+/HER2− metastatic breast cancer after CDK4/6 inhibitors within randomized clinical trials 82
Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials 67
Ten-year outcome results of cT4 breast cancer after neoadjuvant treatment 67
Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis 66
Heterogeneity of progression-free survival surrogacy by sex in randomized trials testing immunotherapy in non-small cell lung cancer 44
One-Year Mortality in Hospitalized, Frail Older Adults with Atrial Fibrillation on Oral Anticoagulant Therapy: Impact of Stroke and Bleeding Events 43
Outcomes, indications and predictive factors for complications in postmastectomy prepectoral reconstructions with polyurethane foam-coated implants 38
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials 8
Totale 10.928
Categoria #
all - tutte 39.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.659


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021745 0 0 0 0 0 136 111 138 69 64 45 182
2021/2022742 81 52 63 33 24 72 33 45 46 79 70 144
2022/20231.251 149 352 172 105 102 185 29 34 24 34 32 33
2023/2024776 18 15 29 72 79 158 106 46 72 40 31 110
2024/20252.649 129 306 135 132 159 138 164 93 296 329 307 461
2025/20263.378 846 772 520 575 544 121 0 0 0 0 0 0
Totale 10.928